Big Pharmai is projected to rise to $0.0003696 by 2027, a +78% move from its current price of $0.0002082. DRUGS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $0.0001938 | $0.0002089 | $0.0002251 | +0.33% |
| Aug 3 | $0.0001885 | $0.0002096 | $0.000233 | +0.66% |
| Aug 4 | $0.0001847 | $0.0002102 | $0.0002394 | +0.99% |
| Aug 5 | $0.0001816 | $0.0002109 | $0.000245 | +1.32% |
| Aug 6 | $0.000179 | $0.0002116 | $0.0002502 | +1.66% |
| Aug 7 | $0.0001767 | $0.0002123 | $0.0002551 | +1.99% |
| Aug 8 | $0.0001747 | $0.000213 | $0.0002597 | +2.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0001747 | $0.000213 | $0.0002597 | +2.33% |
| Week 2 | $0.0001647 | $0.000218 | $0.0002885 | +4.71% |
| Week 3 | $0.0001583 | $0.0002231 | $0.0003144 | +7.15% |
| Week 4 | $0.0001536 | $0.0002283 | $0.0003392 | +9.64% |
| Week 5 | $0.00015 | $0.0002336 | $0.0003638 | +12.20% |
| Week 6 | $0.0001471 | $0.000239 | $0.0003883 | +14.81% |
| Week 7 | $0.0001448 | $0.0002446 | $0.0004131 | +17.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Big Pharmai (DRUGS) is a cryptocurrency token described by its affiliation with the Solana Ecosystem, Meme, AI Meme, Desci Meme, and daos.fun Ecosystem categories. It is a tradable asset whose identity is defined by its symbol DRUGS and its presence in meme and ecosystem-oriented spaces.
The asset currently trades at a tiny price level and is tracked by market metrics such as market cap and rank, reflecting its niche position within a broad crypto landscape. Its all-time price history sets the context for its volatility, with periods at both the high and low ends of its range.
The price journey includes an all-time high of $0.0559 and an all-time low of $0.00006176, illustrating substantial prior movement within its niche market. This framing helps investors assess risk and potential upside as the asset evolves in its category and ecosystem exposure.
Big Pharmai (DRUGS) is presently priced at $0.0001715, with a market cap of $188.66K and a rank of 4694. Its all-time high stands at $0.0559 and its all-time low at $0.00006176, providing a stark range in which the asset has traded.
The year-by-year forecast shows a path of gradual to substantial gains, with the average price moving from $0.0001715 in 2026 toward higher levels in later years. By 2030 the average is projected at $0.0004821 with a max of $0.0008384, and by 2040 and 2050 the forecasted averages rise to $0.001669 and $0.002237, respectively, accompanied by notable ROI figures.
The longer-horizon outlook highlights strong upside potential, with 2033 and 2034 forecasted averages near the mid-to-upper range of a penny, and multi-hundred percent ROI in later years (e.g., 2033 at 385.4%, 2034 at 395.4%, 2040 at 873%, and 2050 at 1204.3%). These projections reflect an expected uptrend across the 2029–2050 window, though they remain estimates and carry inherent uncertainty.
A major floor 52.9% below — a decisive break under it would weaken the trend.
The nearest floor, 34.6% below — buyers have tended to step in here.
The nearest ceiling, 10.1% above — a clean break opens room to run.
A major ceiling 100.0% above — clearing it would confirm fresh momentum.
Key DRUGS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DRUGS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0002115 | Sell | $0.0002067 | Buy |
| MA 10 | $0.0002011 | Buy | $0.0002002 | Buy |
| MA 20 | $0.0001806 | Buy | $0.0001897 | Buy |
| MA 50 | $0.0001717 | Buy | $0.0001781 | Buy |
| MA 100 | $0.0001799 | Buy | $0.0001779 | Buy |
| MA 200 | $0.000154 | Buy | $0.0002581 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.80 | Neutral |
| Stoch RSI (14) | 65.46 | Neutral |
| CCI (20) | 76.76 | Neutral |
| Williams %R (14) | -25.55 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 27.12 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 74.45 | Neutral |
| TRIX (15) | 0.64 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 65.64 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 0.00 | Buy |
| ADX (14) | 16.86 | Neutral |
| ATR (14) | 0.00 | Info |
The 30-day technical picture supports a bullish tone. RSI14 is 60, and the asset trades with SMA50 at $0.0001669 and SMA200 at $0.0001642, placing price action in a constructive zone near key moving averages.
Momentum is accompanied by a defined support at $0.0001317 and a resistance at $0.0001805, with the 30-day price range between $0.0001262 and $0.0002331. The current price sits at $0.0001715, and the 30-day volatility remains elevated in this micro-cap area, reflecting a dynamic setup for short-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.00006208 | $0.0002082 | $0.0004789 | 0% | Neutral | |
| $0.000269 | $0.0003696 | $0.0005489 | +78% | Bullish | |
| $0.0002162 | $0.0003159 | $0.0005006 | +52% | Bullish | |
| $0.0001183 | $0.0001822 | $0.0003032 | -12% | Neutral | |
| $0.0002538 | $0.00041 | $0.0007108 | +97% | Bullish | |
| $0.0002521 | $0.0004257 | $0.0007641 | +104% | Bullish | |
| $0.0001397 | $0.0002462 | $0.0004559 | +18% | Neutral | |
| $0.0002402 | $0.0004408 | $0.0008389 | +112% | Bullish | |
| $0.0002511 | $0.0004795 | $0.0009358 | +130% | Bullish | |
| $0.0002178 | $0.0004325 | $0.0008638 | +108% | Bullish | |
| $0.0001498 | $0.0003328 | $0.000731 | +60% | Bullish | |
| $0.000273 | $0.0006067 | $0.001395 | +191% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.00006208 | $0.0002082 | $0.0002747 | +0.00% |
| September 2026 | $0.0002275 | $0.0002771 | $0.0003523 | +33.08% |
| October 2026 | $0.0002276 | $0.000281 | $0.0003644 | +1.42% |
| November 2026 | $0.0002267 | $0.000283 | $0.0003729 | +0.73% |
| December 2026 | $0.0002841 | $0.0003583 | $0.0004789 | +26.60% |
Click any year to see its month-by-month DRUGS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, DRUGS could reach as high as $0.0004789, with a base case around $0.0002082 and support toward $0.00006208 — roughly 0% from $0.0002082. Price action looks broadly range-bound.
Expect DRUGS to range from $0.000269 to $0.0005489 through 2027. The $0.0003696 average target implies a +78% move from current prices. That is up +78% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The DRUGS price prediction for 2028 points to an average of $0.0003159 (low $0.0002162, high $0.0005006) — a potential gain of +52% on today's $0.0002082. Momentum favours further upside here.
In 2029, DRUGS is projected to trade between $0.0001183 and $0.0003032, averaging $0.0001822 — a potential decline of -12% from today's $0.0002082. That is -42% versus the projected 2028 average. A consolidation phase looks the most probable path here.
Big Pharmai's 2030 outlook centres on $0.00041, within a $0.0002538 to $0.0007108 range. That is up +125% on the projected 2029 average. That marks a +97% change versus current levels. Momentum favours further upside here.
By 2031, DRUGS could reach as high as $0.0007641, with a base case around $0.0004257 and support toward $0.0002521 — roughly +104% from $0.0002082. Buyers look set to stay in control over this stretch.
Expect DRUGS to range from $0.0001397 to $0.0004559 through 2032. The $0.0002462 average target implies a +18% move from current prices. That is -42% versus the projected 2031 average. Price action looks broadly range-bound.
The DRUGS price prediction for 2033 points to an average of $0.0004408 (low $0.0002402, high $0.0008389) — a potential gain of +112% on today's $0.0002082. Buyers look set to stay in control over this stretch.
In 2034, DRUGS is projected to trade between $0.0002511 and $0.0009358, averaging $0.0004795 — a potential gain of +130% from today's $0.0002082. That is up +9% on the projected 2033 average. Momentum favours further upside here.
Big Pharmai's 2035 outlook centres on $0.0004325, within a $0.0002178 to $0.0008638 range. That is -10% versus the projected 2034 average. That marks a +108% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, DRUGS could reach as high as $0.000731, with a base case around $0.0003328 and support toward $0.0001498 — roughly +60% from $0.0002082. Momentum favours further upside here.
Expect DRUGS to range from $0.000273 to $0.001395 through 2050. The $0.0006067 average target implies a +191% move from current prices. That is up +82% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DRUGS today (≈ 4,803,535.402056 DRUGS) could be worth
$2,914.1
+$1,914.1 (+191%) by 2050 · US Dollar
Based on the average projected DRUGS price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DRUGSwould be worth at today's price.
$1,000 invested in DRUGS on Aug 1, 2025 (≈ 521,627.367524 DRUGS) would be worth
$108.59
-$891.41 (-89.1%) today · 0.11× · US Dollar
Based on a DRUGS entry price of $0.001917 vs. today's $0.000208.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.000177 | $1,175.53 | +17.6% |
| 1 month ago | $0.000182 | $1,146.1 | +14.6% |
| 3 months ago | $0.000314 | $664.01 | -33.6% |
| 6 months ago | $0.000126 | $1,649.9 | +65.0% |
| 1 year ago | $0.001917 | $108.59 | -89.1% |
| All time (1.2y) ago | $0.000719 | $289.44 | -71.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DRUGS forecast.
Our base-case forecast reaches $0.00042 around 2031.
Implied market cap at $0.00042: $461.96K
Looking ahead, the multi-year forecast outlines a pronounced upside in the DRUGS price path. In 2029 the average is $0.0003587 with a 109.1% ROI, rising to a 2030 average of $0.0004821 and an 181.1% ROI. The bullish trajectory continues through 2031 ($0.0004748, 176.8%), 2032 ($0.0003277, 91.1%), and 2033 ($0.0008326, 385.4%), with 2034 ($0.0008496, 395.4%) and 2035 ($0.0006079, 254.4%).
By 2040 the average price is forecast at $0.001669 with an 873% ROI, and by 2050 the average reaches $0.002237 with a 1204.3% ROI. The max forecasts illustrate substantial upside as well, with 2033 max $0.001588 and 2034 max $0.001662, culminating in a 2050 max of $0.005145. Throughout these years the sentiment is shown as BULLISH, underscoring an optimistic long-term view while recognizing the uncertainty inherent in price forecasts.
These are estimates, not guarantees, and actual results can differ due to market conditions and other factors. Investors should consider the trajectory as one possible path among many.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $0.0004821 with a max of $0.0008384 and a min of $0.0002973, representing a ROI of 181.1% and a sentiment of BULLISH.
Forecasts indicate a bullish outlook from 2029 onward with a notable ROI, including 109.1% in 2029, 181.1% in 2030, 176.8% in 2031, 385.4% in 2033, 395.4% in 2034, 873% in 2040, and 1204.3% in 2050. Early years (2026–2028) are neutral with lower implied ROIs, reflecting uncertainty and risk.
Yes. The forecast shows a max of $0.001588 in 2033 and $0.001662 in 2034, indicating the asset could surpass $0.001 in those years.
The current price is $0.0001715. The market cap is $188.66K, and the rank is 4694.
Sentiment is BULLISH with RSI14 at 60. The SMA50 is $0.0001669 and the SMA200 is $0.0001642. The 30-day range is $0.0001262–$0.0002331, with support at $0.0001317 and resistance at $0.0001805.
Big Pharmai Community Discussion
0Share your Big Pharmai price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.